Monday
April 27
2020

Report: Countries, Companies Risk Billions in Race for Coronavirus Vaccine

By Julie Steenhuysen, Peter Eisler, Allison Martell, Stephanie Nebehay

In the race to develop a vaccine to end the COVID-19 pandemic, governments, charities and Big Pharma firms are sinking billions of dollars into bets with extraordinarily low odds of success.

They’re fast-tracking the testing and regulatory review of vaccines with no guarantee they will prove effective. They’re building and re-tooling plants for vaccines with slim chances of being approved. They’re placing orders for vaccines that, in the end, are unlikely to be produced.

It’s the new pandemic paradigm, focused on speed and fraught with risks.

Photo courtesy of Army Medicine.

Source: Reuters (link opens in a new window)

Categories
Coronavirus, Health Care
Tags
business, coronavirus, pharmaceutical industry, public health, vaccines